IGM Biosciences, Inc. Made Big Gain

IGM Biosciences, Inc. (IGMS:NASDAQ) soared at $11.47, representing a gain of 36.4%. On Wed, May 22, 2024, IGMS:NASDAQ touched a New 2-Week High of $11.47. The stock got featured on our News Catalysts scanner on Fri, May 10, 2024 at 03:19 PM in the 'BIOTECH' category. From Wed, May 08, 2024, the stock recorded 40.00% Up Days and 27.27% Green Days

About IGM Biosciences, Inc. (IGMS:NASDAQ)

IGM Biosciences Inc is a biotechnology company involved in the development of engineered IgM antibodies for the treatment of cancer patients. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.